DaVita HealthCare Partners Inc (DVA): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

DaVita HealthCare Partners ( DVA) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.2%. By the end of trading, DaVita HealthCare Partners fell $1.46 (-1.3%) to $110.49 on average volume. Throughout the day, 835,962 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 865,400 shares. The stock ranged in price between $110.39-$112.03 after having opened the day at $111.54 as compared to the previous trading day's close of $111.95. Other companies within the Health Services industry that declined today were: Addus Homecare Corporation ( ADUS), down 5.5%, ERBA Diagnostics ( ERB), down 5.5%, Stereotaxis ( STXS), down 5.4% and SunLink Health Systems ( SSY), down 4.7%.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $11.8 billion and is part of the health care sector. Shares are up 1.3% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins.

On the positive front, Sunshine Heart ( SSH), up 14.4%, Unilife Corporation ( UNIS), up 11.6%, CardioNet ( BEAT), up 8.6% and ImmunoCellular Therapeutics ( IMUC), up 8.4% , were all gainers within the health services industry with Edwards Life ( EW) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists